로딩 중…
StockDiggingStockDigging

ClearPoint Neuro, Inc.

CLPT· NASDAQ
$13.74+2.54%
2026-09-17

Financials

Valuation Metrics

ClearPoint Neuro, Inc.'s Market Cap is $412M. At end of 2025 it was $387M. Ranked #2865 of 3,121 in US market (top 92%), #1272 of 1,463 on NASDAQ (top 87%), #177 of 205 in Health Care Equipment & Services (top 86%) by Market Cap.

Investment Metrics(as of 2026-09-18)

MetricValue
Size
Market Cap$412M
Revenue$42M
Net Income$-35M
Total Assets$87M
Net Assets$11M
Employees172
Value
P/B38.24x
P/S9.75x
FCF Yield-7.59%
Profitability
ROA-39.85%
Op. Margin-73.42%
Revenue Growth25.86%
Financial Health
Debt Ratio704.95%
Total Debt$64M
FCF$-31M
Cash$29M
Current Ratio4.73x
Performance
1Y Return28.89%
1M Return-9.49%
From 52W High-54.35%
1Y MDD-70.74%
Trading
Volume471,827 shares
Trading Value$6M
Per Share
EPS$-1.15
BPS$0.36

Company Info

CEO Joseph Michael Burnett
Employees 172
HQ Solana Beach, US

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.